BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8491554)

  • 1. Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells.
    Hackett SF; Campochiaro PA
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2055-61. PubMed ID: 8491554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
    Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells.
    Wilson HM; Reid FJ; Brown PA; Power DA; Haites NE; Booth NA
    Exp Nephrol; 1993; 1(6):343-50. PubMed ID: 8081986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 mRNA expression in cultured pigmented ciliary epithelial cells of the porcine eye.
    Meyer MW; von Depka M; Wilhelm C; Schröder A; Erb C
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):679-86. PubMed ID: 12192463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
    Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture.
    Immonen I; Sirén V; Stephens RW; Liesto K; Vaheri A
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2062-7. PubMed ID: 8491555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
    Blei F; Wilson EL; Mignatti P; Rifkin DB
    J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
    Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
    Glia; 1992; 6(3):163-71. PubMed ID: 1335967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES; Menicucci G; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes.
    Seki T; Miyasu T; Noguchi T; Hamasaki A; Sasaki R; Ozawa Y; Okukita K; Declerck PJ; Ariga T
    J Cell Physiol; 2001 Oct; 189(1):72-8. PubMed ID: 11573206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mRNA phenotype of a human RPE cell line at replicative senescence.
    Matsunaga H; Handa JT; Gelfman CM; Hjelmeland LM
    Mol Vis; 1999 Dec; 5():39. PubMed ID: 10617776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen modulates the release of urokinase and plasminogen activator inhibitor-1 by retinal pigment epithelial cells.
    Erichsen JT; Jarvis-Evans J; Khaliq A; Boulton M
    Int J Biochem Cell Biol; 2001 Mar; 33(3):237-47. PubMed ID: 11311855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
    Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
    Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.